In an interview, Nik Leist, Senior Director, Ingestible Sensor Manufacturing and Site Leader, Proteus Digital Health with Chemical Today magazine talks in depth about how the convergence of digital technologies and healthcare is fundamentally changing the way patients interact with their own health. He delves into ways in which mobile applications and wearable devices are actively engaging with medication like never before.
Leist is a keynote speaker for CPhI North America conference.
By Shivani Mody
Insight into Digital Medicines.
Digital Medicines consist of oral pharmaceuticals formulated with an ingestible sensor which communicates with the patient’s mobile device when they have been swallowed. This technology supports patient self-care and physician decision making, in that both parties can observe medication-taking behaviors, and tailor treatment the plans as per the needs of the patient.
Digital Medicines, developed over the last 16 years, and used in real-world over the last 2.5 years, is a driver of this change. This new category of pharmaceuticals, pairing medications with sensors, opens the door for more informed decisions and conversations across the healthcare field and enables a true integration of technology directly into medications. Customizing machinery and partnering with global pharmaceutical companies are some of the steps which can expand the horizons of Digital Medicines.
In an interview, Nik Leist, Senior Director, Ingestible Sensor Manufacturing and Site Leader, Proteus Digital Health with Chemical Today magazine talks in depth about how the convergence of digital technologies and healthcare is fundamentally changing the way patients interact with their own health. He delves into ways in which mobile applications and wearable devices are actively engaging with medication like never before.
Leist is a keynote speaker for CPhI North America conference.
By Shivani Mody
Insight into Digital Medicines.
Digital Medicines consist of oral pharmaceuticals formulated with an ingestible sensor which communicates with the patient’s mobile device when they have been swallowed. This technology supports patient self-care and physician decision making, in that both parties can observe medication-taking behaviors, and tailor treatment the plans as per the needs of the patient.
Digital Medicines, developed over the last 16 years, and used in real-world over the last 2.5 years, is a driver of this change. This new category of pharmaceuticals, pairing medications with sensors, opens the door for more informed decisions and conversations across the healthcare field and enables a true integration of technology directly into medications. Customizing machinery and partnering with global pharmaceutical companies are some of the steps which can expand the horizons of Digital Medicines.
No comments:
Post a Comment